Local, Open, Non-Randomized, Phase IV Clinical Study for the Collection of Data Regarding the Drug Portability Received During the Treatment With Subcutaneous Injection of Apidra Glulisin (HMR1964) [insulin glulisine] to Patients With Diabetes Melitus 1st Type.
Phase of Trial: Phase IV
Latest Information Update: 07 Jul 2009
At a glance
- Drugs Insulin glulisine (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Sanofi
- 02 Aug 2007 New trial record.